CCL2 and lupus nephritis: In comparison with serum immunoproteins (e.g., serum MCP-1 (sMCP-1)), the urinary immunomediators (e.g., urine MCP-1 (uMCP-1)) are identified as dominant biomarkers of lupus nephritis (LN) in patients with SLE.